{
  "id": "pharma-controversy",
  "label": "ðŸ’Š Pharma Controversy",
  "category": "health",
  "type": "warning",
  "definition": "Pharmaceutical company involved in significant controversies including price gouging, misleading marketing, or opioid crisis.",
  "criteria": [
    {
      "description": "Significant legal settlements for deceptive marketing practices"
    },
    {
      "description": "Involvement in opioid epidemic (manufacturing, distribution, promotion)"
    },
    {
      "description": "Documented extreme price increases for essential medications"
    },
    {
      "description": "Delayed generic drug availability through pay-for-delay deals"
    }
  ],
  "counterCriteria": [
    "Full remediation of issues with independent verification",
    "Changed practices with regulatory approval"
  ],
  "references": [
    {
      "title": "Violation Tracker - Pharma",
      "url": "https://violationtracker.goodjobsfirst.org/",
      "description": "Pharmaceutical company violations database"
    },
    {
      "title": "Access to Medicine Index",
      "url": "https://accesstomedicinefoundation.org/",
      "description": "Pharmaceutical company access rankings"
    }
  ],
  "relatedTags": [],
  "created": "2026-02-01T00:00:00Z"
}
